| Yaser Baghdadi, MD MSC | |
|
10112 Avalon Gates, Trumbull, CT 06611-5836 | |
| (507) 271-8918 | |
| Not Available |
| Full Name | Yaser Baghdadi |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 10112 Avalon Gates, Trumbull, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962884700 | NPI | - | NPPES |
| Entity Name | Brookview Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871965855 PECOS PAC ID: 9537420450 Enrollment ID: O20180309000532 |
News Archive
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.
New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.
According to Canadian researchers any kind of exercise is better than none when it comes to controling type-2 diabetes.
Agilent Technologies Inc. today announced the winners of the 2011 eMerging Insights grant program: Dr. Michael J. MacCoss of the University of Washington and Dr. Peter J. Park of Harvard University. Each will be awarded $75,000 toward their ongoing research on open source data-integration tools.
Mylan N.V. today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer's Zyvox Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yaser Baghdadi, MD MSC 10112 Avalon Gates, Trumbull, CT 06611-5836 Ph: (507) 271-8918 | Yaser Baghdadi, MD MSC 10112 Avalon Gates, Trumbull, CT 06611-5836 Ph: (507) 271-8918 |
News Archive
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.
New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.
According to Canadian researchers any kind of exercise is better than none when it comes to controling type-2 diabetes.
Agilent Technologies Inc. today announced the winners of the 2011 eMerging Insights grant program: Dr. Michael J. MacCoss of the University of Washington and Dr. Peter J. Park of Harvard University. Each will be awarded $75,000 toward their ongoing research on open source data-integration tools.
Mylan N.V. today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer's Zyvox Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.
› Verified 8 days ago